Stockreport

Opus Genetics: Asymmetric Upside With LCA5 And BEST1 [Seeking Alpha]

Opus Genetics, Inc.  (IRD) 
PDF Its lead candidate is OPGx-LCA5, which is moving into Phase 3 enrollment. Interestingly, OPGx-LCA5's Phase 1/2 showed encouraging safety and functional vision improvem [Read more]